Results 91 to 100 of about 2,975 (223)

Low-dose naltrexone: a novel adjunctive treatment in symptomatic alopecias? [PDF]

open access: yes, 2019
Naltrexone is a competitive antagonist of μ, κ and γ opioid receptors, used for treatment of alcoholism and opioid addiction. Low-dose naltrexone (LDN) is defined as daily doses ranging from 1mg to 5mg. This is purported to have a paradoxical effect that
de Mattos, Taynara   +4 more
core  

Graham-Little Syndrome — a rare entity of both scarring and non-scarring alopecia concomitance [PDF]

open access: yes, 2019
Graham Little-Piccardi-Lassueur syndrome also called in a shorter form as Graham-Little syndrome, is a rare clinical entity characterized by the symptomatic triad including multifocal progressive cicatricial alopecia on the scalp, non-scarring hair loss ...
Czuwara, Joanna   +3 more
core   +2 more sources

Frontal fibrosing alopecia:reflections and hypotheses on etiology and pathogenesis [PDF]

open access: yes, 2016
Since it was first described by Kossard in 1994, frontal fibrosing alopecia (FFA) has been something of an enigma. The clinical heterogeneity of FFA, its apparent rarity, and investigators' suboptimal access to phenotypically consistent patient cohorts ...
Fenton, David A   +4 more
core   +2 more sources

Lichen Planopilaris Induced by Checkpoint Inhibitors: A Systematic Review

open access: yes
International Journal of Dermatology, EarlyView.
Niyoosha Yoosefi   +2 more
wiley   +1 more source

Nail Lichen Planus in 81 Patients: A Retrospective Study of Clinical Characteristics, Histopathological Features, and Long‐Term Treatment Outcomes

open access: yesThe Journal of Dermatology, Volume 52, Issue 11, Page 1629-1637, November 2025.
ABSTRACT Nail lichen planus (NLP) is a rare, chronic inflammatory nail disorder that can result in irreversible damage. While clinical awareness is growing, long‐term real‐world data—particularly incorporating histopathological confirmation and treatment outcomes—remains limited.
Juan He   +6 more
wiley   +1 more source

Inflammasome Activation Characterizes Lesional Skin of Folliculitis Decalvans

open access: yesActa Dermato-Venereologica, 2018
Folliculitis decalvans (FD) is a chronic inflammatory disease leading to scarring alopecia with poorly defined pathogenesis. The aim of this study was to investigate the expression of markers associated with the activation of innate immune signals, such ...
Alexia Eyraud   +6 more
doaj   +1 more source

Frontal Fibrosing Alopecia and Its Association With Genital Lichen Planus and Lichen Sclerosus: A Systematic Review

open access: yes
International Journal of Dermatology, EarlyView.
Samantha Bestavros   +2 more
wiley   +1 more source

Clinical recognition and management of alopecia in women of color,

open access: yesInternational Journal of Women's Dermatology, 2019
Certain types of alopecia, such as traction alopecia, discoid lupus erythematosus, and central centrifugal cicatricial alopecia, occur more commonly in African-American individuals than in those of other ethnicities.
Jodie Raffi, BA   +2 more
doaj   +1 more source

Clinicohistopathologic study of lichenoid interface dermatitis

open access: yesArchives of Medicine and Health Sciences, 2020
Background: Interface dermatitis (IFD)/lichenoid tissue reactions are among the most frequently presenting disorders in dermatology, which in common have a constellation of histopathological features but varied clinical presentation.
Aparna Muralidhar   +2 more
doaj   +1 more source

Development of the Hair & Scalp CARE questionnaire: Measuring the impact of hair and scalp issues on psychological wellbeing in healthy populations

open access: yesInternational Journal of Cosmetic Science, Volume 47, Issue 5, Page 807-819, October 2025.
The Hair & Scalp CARE questionnaire is a validated tool for assessing the impact of hair and scalp condition on psychological wellbeing. The present data also suggest greater hair and scalp wellbeing is linked to lower levels of perceived stress and good sleep health.
Alice Newton‐Fenner   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy